IDXX
Idexx Laboratories, Inc.

2,878
Loading...
Loading...
News
all
press releases
Should You Add IDEXX Stock to Your Portfolio Right Now?
IDXX shows strong CAG Diagnostics growth, cloud software momentum and global expansion but faces solvency and macro risks.
Zacks·9h ago
News Placeholder
More News
News Placeholder
Is Climb Bio, Inc. (CLYM) Stock Outpacing Its Medical Peers This Year?
Here is how Climb Bio, Inc. (CLYM) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
Zacks·1d ago
News Placeholder
Why Is Idexx (IDXX) Down 0.4% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9d ago
News Placeholder
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Zacks·14d ago
News Placeholder
DGX Stock Gains Following a New Joint Venture With Corewell Health
Quest Diagnostics shares rise after forming a joint venture with Corewell Health to expand advanced lab services across Michigan.
Zacks·15d ago
News Placeholder
If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks·15d ago
News Placeholder
Should You Add IDEXX Stock to Your Portfolio Right Now?
IDXX gains from strong CAG Diagnostics growth and rising cloud software demand, but debt levels remain a concern for investors.
Zacks·16d ago
News Placeholder
Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?
Here is how Encompass Health (EHC) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
Zacks·17d ago
News Placeholder
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·18d ago
News Placeholder
IDEXX Gains 56.2% in a Year: What's Driving the Rally?
IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.
Zacks·18d ago

Latest IDXX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.